Michael D. Bright

Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control

Charlotte Pawlyn, Michael D. Bright, Amy Buros et al. · Blood Cancer Journal · 2017 · 103 citations · Full text

Achieving <i>In Vivo</i> Target Depletion through the Discovery and Optimization of Benzimidazolone BCL6 Degraders

Benjamin R. Bellenie, Kwai-Ming J. Cheung, Ana Varela et al. · Journal of Medicinal Chemistry · 2020 · 72 citations · Full text

Cleavage of <i>BLOC1S1</i> mRNA by IRE1 Is Sequence Specific, Temporally Separate from <i>XBP1</i> Splicing, and Dispensable for Cell Viability under Acute Endoplasmic Reticulum Stress

Michael D. Bright, Daniel N. Itzhak, Christopher P. Wardell et al. · Molecular and Cellular Biology · 2015 · 66 citations · Full text

Acute Er Stress, Transcriptional Regulation, Signal Transduction +15

HSF1 Is Essential for Myeloma Cell Survival and A Promising Therapeutic Target

Jacqueline H. L. Fok, Somaieh Hedayat, Lei Zhang et al. · Clinical Cancer Research · 2018 · 56 citations · Full text

The motor protein myosin 1G functions in FcγR-mediated phagocytosis

Anna Dart, Sylvain Tollis, Michael D. Bright et al. · Journal of Cell Science · 2012 · 45 citations

Unconventional Class-i Myosin, Cup Closure, Immunology +16